BeiGene, Ltd. (BGNE)

BeiGene Statistics

Total Valuation

BeiGene has a market cap or net worth of $20.67 billion. The enterprise value is $18.98 billion.

Market Cap	20.67B
Enterprise Value	18.98B

Important Dates

The last earnings date was Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BeiGene has 106.25 million shares outstanding. The number of shares has decreased by -0.07% in one year.

Current Share Class	n/a
Shares Outstanding	106.25M
Shares Change (YoY)	-0.07%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	8.03%
Owned by Institutions (%)	49.09%
Float	57.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.05
Forward PS	3.53
PB Ratio	6.01
P/TBV Ratio	6.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.

Current Ratio	1.94
Quick Ratio	1.64
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-57.74

Financial Efficiency

Return on equity (ROE) is -23.22% and return on invested capital (ROIC) is -12.29%.

Return on Equity (ROE)	-23.22%
Return on Assets (ROA)	-9.58%
Return on Capital (ROIC)	-12.29%
Revenue Per Employee	$316,161
Profits Per Employee	-$80,606
Employee Count	10,600
Asset Turnover	0.58
Inventory Turnover	1.44

Taxes

In the past 12 months, BeiGene has paid $53.11 million in taxes.

Income Tax	53.11M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.37% in the last 52 weeks. The beta is 0.63, so BeiGene's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	+2.37%
50-Day Moving Average	212.18
200-Day Moving Average	174.70
Relative Strength Index (RSI)	38.26
Average Volume (20 Days)	310,468

Short Selling Information

Short Interest	1.09M
Short Previous Month	1.51M
Short % of Shares Out	2.10%
Short % of Float	n/a
Short Ratio (days to cover)	2.93

Income Statement

In the last 12 months, BeiGene had revenue of $3.35 billion and -$854.42 million in losses. Loss per share was -$8.19.

Revenue	3.35B
Gross Profit	2.80B
Operating Income	-886.48M
Pretax Income	-65.61M
Net Income	-854.42M
EBITDA	-794.98M
EBIT	-886.48M
Loss Per Share	-$8.19

Balance Sheet

The company has $2.71 billion in cash and $1.05 billion in debt, giving a net cash position of $1.66 billion or $15.64 per share.

Cash & Cash Equivalents	2.71B
Total Debt	1.05B
Net Cash	1.66B
Net Cash Per Share	$15.64
Equity (Book Value)	3.45B
Book Value Per Share	32.32
Working Capital	1.89B

Cash Flow

In the last 12 months, operating cash flow was -$649.87 million and capital expenditures -$541.71 million, giving a free cash flow of -$1.15 billion.

Operating Cash Flow	-649.87M
Capital Expenditures	-541.71M
Free Cash Flow	-1.15B
FCF Per Share	-$10.87

Margins

Gross margin is 83.67%, with operating and profit margins of -26.45% and -25.50%.

Gross Margin	83.67%
Operating Margin	-26.45%
Pretax Margin	-23.91%
Profit Margin	-25.50%
EBITDA Margin	-23.72%
EBIT Margin	-26.45%
FCF Margin	-5.81%

Dividends & Yields

BeiGene does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.07%
Shareholder Yield	0.07%
Earnings Yield	-4.20%
FCF Yield	-5.68%

Analyst Forecast

The average price target for BeiGene is $247.07, which is 26.99% higher than the current price. The consensus rating is "Buy".

Price Target	$247.07
Price Target Difference	26.99%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	84.05%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BeiGene has an Altman Z-Score of 2.96 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.96
Piotroski F-Score	4